Celltrion Inc
KRX:068270
Celltrion Inc
Operating Income
Celltrion Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Celltrion Inc
KRX:068270
|
Operating Income
₩651.5B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
14%
|
CAGR 10-Years
21%
|
|
SK Bioscience Co Ltd
KRX:302440
|
Operating Income
-₩12B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Green Cross Corp
KRX:006280
|
Operating Income
₩34.4B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-8%
|
|
H
|
Hugel Inc
KOSDAQ:145020
|
Operating Income
₩117.8B
|
CAGR 3-Years
15%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
P
|
PharmaResearch Co Ltd
KOSDAQ:214450
|
Operating Income
₩92.3B
|
CAGR 3-Years
40%
|
CAGR 5-Years
60%
|
CAGR 10-Years
N/A
|
A
|
Alteogen Inc
KOSDAQ:196170
|
Operating Income
-₩9.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
See Also
What is Celltrion Inc's Operating Income?
Operating Income
651.5B
KRW
Based on the financial report for Dec 31, 2023, Celltrion Inc's Operating Income amounts to 651.5B KRW.
What is Celltrion Inc's Operating Income growth rate?
Operating Income CAGR 10Y
21%
Over the last year, the Operating Income growth was 1%. The average annual Operating Income growth rates for Celltrion Inc have been -3% over the past three years , 14% over the past five years , and 21% over the past ten years .